Low-level laser therapy for zymosan-induced arthritis in rats: Importance of illumination time

Lasers in Surgery and Medicine

Volumn 39, Issue 6, 2007, Pages 543-550

  Castano, Ana P ^a,b   Dai, Tianhong ^a,b   Yaroslavsky, Ilya ^c   Cohen, Richard ^c   Apruzzese, William A ^c   Smotrich, Michael H ^c   Hamblin, Michael R ^a,b,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Palomar Medical Technologies Inc   (United States)

^d HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

Biostimulation; Cold laser; Low level light therapy; Photobiomodulation; Prostaglandin E2; Zymosan induced arthritis

Indexed keywords

DEXAMETHASONE; PROSTAGLANDIN E2; ZYMOSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; FEMALE; INFLAMMATION; KNEE ARTHRITIS; LIGHT INTENSITY; LOW LEVEL LASER THERAPY; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS; DEXAMETHASONE; DINOPROSTONE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; LASER THERAPY, LOW-LEVEL; POLYSACCHARIDES; RATS; RATS, INBRED LEW; TIME FACTORS; ZYMOSAN;

EID: 34547737436     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.20516     Document Type: Article

References (33)

1. Cooper NJ. Economic burden of rheumatoid arthritis: A systematic review. Rheumatology (Oxford) 2000;39(1):28-33.
2. Harris ED, Jr. The bone and joint decade: A catalyst for progress. Arthritis Rheum 2001;44(9):1969-1970.
3. Mitchell JA, Larkin S, Williams TJ. Cyclooxygenase-2: Regulation and relevance in inflammation. Biochem Pharmacol 1995;50(10):1535-1542.
4. Chan FK, Graham DY. Review article: Prevention of non-steroidal anti-inflammatory drug gastrointestinal complications - review and recommendations based on risk assessment. Aliment Pharmacol Ther 2004;19(10):1051-1061.
5. White WB, Strand V, Roberts R, Whelton A. Effects of the cyclooxygenase-2 specific inhibitor valdecoxib versus nonsteroidal antiinflammatory agents and placebo on cardiovascular thrombotic events in patients with arthritis. Am J Ther 2004;11(4):244-250.
6. White WB, Faich G, Borer JS, Makuch RW. Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib. Am J Cardiol 2003;92(4):411-418.
7. Zarraga IG, Schwarz ER. Coxibs and heart disease: What we have learned and what else we need to know. J Am Coll Cardiol 2007;49(1):1-14.
8. Skelly MM, Hawkey CJ. Potential alternatives to COX 2 inhibitors. Bmj 2002;324(7349):1289-1290.
9. Eells JT, Henry MM, Summerfelt P, Wong-Riley MT, Buchmann EV, Kane M, Whelan NT, Whelan HT. Therapeutic photobiomodulation for methanol-induced retinal toxicity. Proc Natl Acad Sci USA 2003;100(6):3439-3444.
10. Whelan HT, Buchmann EV, Dhokalia A, Kane MP, Whelan NT, Wong-Riley MT, Eells JT, Gould LJ, Hammamieh R, Das R, Jett M. Effect of NASA light-emitting diode irradiation on molecular changes for wound healing in diabetic mice. J Clin Laser Med Surg 2003;21(2):67-74.
11. Soriano F, Campana V, Moya M, Gavotto A, Simes J, Soriano M, Soriano R, Spitale L, Palma J. Photobiomodulation of pain and inflammation in microcrystalline arthropathies: Experimental and clinical results. Photomed Laser Surg 2006;24(2):140-150.
12. Stergioulas A. Low-level laser treatment can reduce edema in second degree ankle sprains. J Clin Laser Med Surg 2004;22(2):125-128
13. Enwemeka CS, Parker JC, Dowdy DS, Harkness EE, Sanford LE, Woodruff LD. The efficacy of low-power lasers in tissue repair and pain control: A meta-analysis study. Photomed Laser Surg 2004;22(4):323-329.
14. Gur A, Sarac AJ, Cevik R, Altindag O, Sarac S. Efficacy of 904 nm gallium arsenide low level laser therapy in the management of chronic myofascial pain in the neck: A double-blind and randomize-controlled trial. Lasers Surg Med 2004;35(3):229-235.
15. Bjordal JM, Johnson MI, Iversen V, Aimbire F, Lopes-Martins RA. Photoradiation in acute pain: A systematic review of possible mechanisms of action and clinical effects in randomized placebo-controlled trials. Photomed Laser Surg 2006;24(2):158-168.
16. Wong-Riley MT, Liang HL, Eells JT, Chance B, Henry MM, Buchmann E, Kane M, Whelan HT. Photobiomodulation directly benefits primary neurons functionally inactivated by toxins: Role of cytochrome c oxidase. J Biol Chem 2005;280(6):4761-4771.
17. Karu TI, Pyatibrat LV, Afanasyeva NI. A novel mitochondrial signaling pathway activated by visible-to-near infrared radiation. Photochem Photobiol 2004;80(2):366-372.
18. Karu T. Primary and secondary mechanisms of action of visible to near-IR radiation on cells. J Photochem Photobiol B 1999;49(1):1-17.
19. Tuner J, Hode L. It's all in the parameters: A critical analysis of some well-known negative studies on low-level laser therapy. J Clin Laser Med Surg 1998;16(5):245-248.
20. Di Carlo FJ, Fiore JV. On the composition of zymosan. Science 1958;127(3301):756-757.
21. de Hooge AS, van De Loo FA, Arntz OJ, van Den Berg WB. Involvement of IL-6, apart from its role in immunity, in mediating a chronic response during experimental arthritis. Am J Pathol 2000;157(6):2081-2091.
22. Underhill DM, Ozinsky A, Hajjar AM, Stevens A, Wilson CB, Bassetti M, Aderem A. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 1999;401(6755):811-815.
23. Keystone EC, Schorlemmer HU, Pope C, Allison AC. Zymosan-induced arthritis: A model of chronic proliferative arthritis following activation of the alternative pathway of complement. Arthritis Rheum 1977;20(7):1396-1401.
24. Frasnelli ME, Tarussio D, Chobaz-Peclat V, Busso N, So A. TLR2 modulates inflammation in zymosan-induced arthritis in mice. Arthritis Res Ther 2005;7(2):R370-379.
25. da SRJC, Peixoto ME, Jancar S, de QCF, de ARR, da Rocha FA. Dual effect of nitric oxide in articular inflammatory pain in zymosan-induced arthritis in rats. Br J Pharmacol 2002;136(4):588-596.
26. Gavish L, Asher Y, Becker Y, Kleinman Y. Low level laser irradiation stimulates mitochondrial membrane potential and disperses subnuclear promyelocyte leukemia protein. Lasers Surg Med 2004;35(5):369-376.
27. Lane N. Cell biology: Power games. Nature 2006;443(7114):901-903.
28. Loeb J, Northrop JH. Heliotropic animals as photometers on the basis of the validity of the Bunsen-Roscoe Law for heliotropic reactions. Proc Natl Acad Sci USA 1917;3(9):539-544.
29. Schindl A, Rosado-Schlosser B, Trautinger F. Reciprocity regulation in photobiology. An overview. Hautarzt 2001;52(9):779-785.
30. Azevedo LH, de Paula Eduardo F, Moreira MS, de Paula Eduardo C, Marques MM. Influence of different power densities of LILT on cultured human fibroblast growth: A pilot study. Lasers Med Sci 2006;21(2):86-89.
31. van Breugel HH, Bar PR. Power density and exposure time of He-Ne laser irradiation are more important than total energy dose in photo-biomodulation of human fibroblasts in vitro. Lasers Surg Med 1992;12(5):528-537.
32. Bjordal JM, Lopes-Martins RA, Iversen VV. A randomised, placebo controlled trial of low level laser therapy for activated Achilles tendinitis with microdialysis measurement of peritendinous prostaglandin E2 concentrations. Br J Sports Med 2006;40(1):76-80; discussion 76-80.
33. Brosseau L, Robinson V, Wells G, Debie R, Gam A, Harman K, Morin M, Shea B, Tugwell P. Low level laser therapy (Classes I, II and III) for treating rheumatoid arthritis. Cochrane Database Syst Rev 2005;(4):CD002049.